Search PubMed⌕ Search

Biomedical subjects

V F Tapson

Publications and source records attributed to V F Tapson.

64 records · Page 4Linked to original sources

Massive pulmonary embolism. Diagnostic and therapeutic strategies.

Massive PE is a devastating clinical entity often undiscovered until autopsy. Acute right ventricular failure may progress to death within minutes to hours after the embolic event and prompt diagnostic and therapeutic intervention are imperative. The diagnosis heavily relies on clinical suspicion together with ventilation-perfusion scanning. Echocardiography may have a role in select patients to aid in the recognition of PE with right ventricular failure and to guide therapy. Clinical instability may hinder the diagnostic evaluation and delay therapeutic intervention. Oxygen is administered and, when necessary, intubation and mechanical ventilation are undertaken. In the setting of hypotension supportive therapy includes vasoactive medications, such as norepinephrine. Intravenous fluids should be administered cautiously. Therapeutic options aimed directly at reducing the embolic burden include systemic thrombolytic therapy, surgical embolectomy, and the use of intrapulmonary arterial catheter techniques. In the absence of contraindications, thrombolytic therapy should be strongly considered in hypotensive patients. Surgical embolectomy for acute PE is controversial, but this modality appears to have a role in select patients. Various intrapulmonary arterial catheter techniques, with or without low-dose thrombolytic therapy, have been used successfully to reduce the embolic burden, although no particular technique appears to have clear advantages over others. Placement of an inferior vena caval filter may prevent additional, potentially fatal emboli and appears appropriate in select patients with massive emboli.

Algorithms↗

Thrombolytic therapy for venous thromboembolism. Utilization by practicing pulmonologists.

BACKGROUND: Pulmonary embolism (PE) is a potentially life-threatening condition for which thrombolytic therapy may be useful, although the appropriate setting, agent, and duration of therapy remain controversial. Deep venous thrombosis (DVT) can cause substantial morbidity and can be complicated by PE. METHODS: A questionnaire was submitted to 100 randomly selected practicing pulmonary physicians in 10 southeastern states. We sought to determine how physicians use thrombolytic therapy in PE and DVT. Characteristics of physicians, such as practice setting and the number of cases of PE and DVT treated in the last 2 years, were obtained. Physicians were asked if they would strongly consider the use of these agents in a variety of PE or DVT scenarios. RESULTS: Responses were tabulated from 56 practicing pulmonary physicians. Thirty-eight (70%) of responding physicians were in private practice. Fifty-four percent of physicians had used thrombolytic agents for acute PE, while only 28% had used them for DVT. All physicians who responded favored treating massive PE associated with hypotension with thrombolytic therapy, and 73% would strongly consider this treatment for acute PE associated with severe hypoxemia. Agreement on treatment in other scenarios was less uniform. CONCLUSIONS: Pulmonary physicians strongly favored thrombolytic therapy for massive PE associated with hypotension in the absence of absolute contraindications. A majority favored their use in PE associated with severe hypoxemia in the absence of hypotension or in massive proximal DVT present less than 7 days. Further prospective, multicenter, randomized trials appear indicated. Examining crucial end points, such as mortality, may help to unify therapeutic strategies and further refine the guidelines for the use of these agents in venous thromboembolism.

Humans↗

Isolation of mycobacteria in patients with pulmonary alveolar proteinosis.

Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by accumulation of proteinaceous material in the alveoli of affected individuals. Pulmonary infections appear to develop with increased frequency in these patients. The increased rate of infection has been attributed to immunologic aberrations, such as impaired alveolar macrophage function, particularly when uncommon pathogens are involved. Among those pathogens, Nocardia asteroides and Mycobacterium tuberculosis have appeared most often in case reports in the literature. Mycobacterium avium-intracellulare (MAI) has rarely been isolated in these patients. We report an unusually high incidence of MAI isolation from lavage fluid in 8 of 19 consecutive patients who underwent therapeutic lung lavage for relief of symptomatic PAP, and summarize the available literature on isolation of potential respiratory pathogens in PAP.

Adult↗

Rapid visualization of massive pulmonary emboli utilizing intravascular ultrasound.

Massive pulmonary embolism may result in rapid deterioration prior to diagnostic and therapeutic intervention. Intravascular ultrasound imaging has been utilized previously to evaluate vascular abnormalities as well as normal human pulmonary arteries. We employed this technique to rapidly identify massive pulmonary emboli located in the main pulmonary arteries of two patients. The presence of these emboli was confirmed with pulmonary arteriography. Intravascular ultrasound may be utilized to rapidly confirm the presence of large proximal pulmonary emboli.

Aged↗

Pharmacomechanical thrombolysis of experimental pulmonary emboli. Rapid low-dose intraembolic therapy.

We utilized low-dose intraembolic urokinase (UK) infusions in a canine model of experimental pulmonary embolism (PE) and compared the arteriographic extent of thrombolysis with three other treatment regimens. Group 1 animals (n = 16) received the intraembolic UK infused directly into the PE offering the mechanical effect of the infusion combined with pharmacologic thrombolysis. In the group 2 animals (n = 5), UK was delivered via a guide catheter placed proximal to the clot. Group 3 animals (n = 6) were treated with a direct intraembolic saline solution infusion. Group 4 (n = 7) received only intravenous heparin. The arteriographic extent of thrombolysis was graded 1+ to 3+. The extent of thrombolysis was 2.88+ in the group 1 animals and was significantly greater than in groups 2, 3, or 4 (p = 0.003, 0.0005, and 0.0001, respectively). Fibrinogen levels did not significantly decrease with intraembolic treatment (p = 0.07). Delivery of UK directly into emboli in an experimental canine PE model appears to elicit a combined mechanical and pharmacologic effect resulting in extensive thrombolysis.

Animals↗

Rapid and accurate diagnosis of pulmonary emboli in a canine model using intravascular ultrasound imaging.

We utilized intravascular ultrasound (IVUS) imaging in a canine pulmonary embolism model to visualize experimental emboli. The images obtained were compared with those obtained by single-plane pulmonary arteriography in each of six animals. The vessel lumen appeared patent by both methods prior to injection of autologous clot. After thrombi were injected, the vessels were again imaged using both techniques. Intravascular ultrasound was 100 percent sensitive in detecting emboli, and visualization was always rapid. There were no complications. It appears that IVUS imaging is a sensitive method for documenting the presence of clot in a canine pulmonary embolism model.

Animals↗

Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro.

Growth factor receptors for T lymphocytes, such as interleukin 2 and insulin, are present on activated but not resting T lymphocytes. We sought to determine if insulin-like growth factor I (IGF-I) could act as a growth factor for human T cells and to characterize its receptor on resting and activated cells. Recombinant IGF-I induced two separate functions. It was chemotactic for and increased incorporation of tritiated thymidine into both unactivated (resting) and mitogen-activated T cells. High-affinity 125I-IGF-I binding to human T cells was saturable with an apparent Kd of 1.2 +/- .6 X 10(-10) M for binding to activated T cells and 1.2 +/- .9 X 10(-10) for unactivated T cells. The calculated binding for activated cells was 330 +/- 90 and for resting cells 45 +/- 9 high-affinity receptor sites per cell. Affinity cross-linking of 125I-IGF-I to resting or activated T cells revealed a radioligand-receptor complex of 360,000 mol wt when analyzed by SDS-PAGE without reduction and complexes of 270,000 and 135,000 mol wt upon reduction; prior incubation with excess unlabeled IGF-I prevented formation of the 125I-IGF-I receptor complex. Our data suggest that both resting and activated T lymphocytes bear functional IGF-I receptors similar to those found in other tissues. These receptors may mediate T cell growth and chemotaxis.

Affinity Labels↗

Detection of deep venous thrombosis: prospective comparison of MR imaging and sonography.

Seventy-five patients (41 women and 34 men, 20-85 years old) with clinically suspected deep venous thrombosis (DVT) were examined with MR imaging and sonography. In 26 patients, the final diagnosis was acute femoropopliteal DVT. The sensitivity of MR imaging for detecting this disease was 100% with a 95% confidence interval (CI) of 87-100%; the specificity was 100% with a CI of 92-100%; and the accuracy was 96% with a CI of 89-99%. The correspond-ing sensitivity of sonography was 77% with a CI of 53-92%; the specificity was 98% with a CI of 89-100%; and the accuracy was 83% with a CI of 72-90%. In four of the 75 patients, MR images revealed thrombus of the pelvis (n = 1) or calf (n = 3) without femoropopliteal involvement. The estimated prevalence of isolated calf and/or pelvic DVT was 5% with a CI of 1-13%. MR imaging is significantly more sensitive (P = .02) and accurate (P < .01) than sonography in the detection of lower extremity DVT, but there was no difference in the specificity of MR imaging and that of sonography (P = .31).

Adult↗

Prospective comparison of helical CT and MR imaging in clinically suspected acute pulmonary embolism.

The purpose of this study is to compare sensitivity and specificity of helical CT and MR imaging for detecting acute pulmonary embolism(PE). Patients who were suspected clinically of having PE were randomly assigned to undergo either helical contrast-enhanced CT or gradient-echo MR (if one modality was contraindicated, the patient was assigned to the other.) Patients were considered to have PE if they had: 1) high-probability V-Q scan and low clinical probability of PE; 2) pulmonary angiogram positive for PE. Patients were considered not to have PE if they had either:1)normal V-Q scan; 2) low probability V-Q scan and low clinical probability of PE; or 3) pulmonary angiogram negative for PE. The CT and MR images were read randomly and independently by five radiologists with varying levels of CT and MR experience. Twenty eight patients underwent CT and 25 MR. A total of 21 patients underwent pulmonary angiography (6 had PE, 15 did not have PE). Of the other 32 patients, 15 had high probability scan/high clinical probability and 17 had low probability scan/low clinical probability. For the five observers, the average sensitivity of CT was 75% and of MR 46%; the average specificity of CT was 89% and of MR 90%. Experience with vascular MR and enhanced CT influenced diagnostic accuracy. For the two vascular MR experts, average sensitivity and specificity of MR were 71% and 97%, and of CT 73% and 97%. In this pilot study, when CT and MR were interpreted with comparable expertise, they had similar accuracy for detecting pulmonary embolism.

Adult↗

Delivery of intravenous treprostinil at low infusion rates using a miniaturized infusion pump in patients with pulmonary arterial hypertension.

PURPOSE: Treprostinil is approved for the treatment of pulmonary arterial hypertension (PAH) via continuous intravenous (IV) infusion. Treprostinil's anti-platelet aggregation characteristics and stability at room temperature may allow for low infusion rates (0.1-0.2 mL/hr) using a miniaturized infusion pump. METHODS: A 12-week, multi-center, open-label study in 12 adult PAH patients, evaluated the feasibility and safety of low-flow IV treprostinil administration via the 407C miniaturized pump. Patients receiving IV treprostinil at a stable dose were transitioned from their current CADD-Legacy pump to the 407C and were assessed for adverse events including catheter occlusions, pump alarms, and efficacy (six minute walk distance (6MWD), Borg Dyspnea Score (BDS), NYHA functional class, and PAH signs/symptoms). All patients were also maintained on therapeutic doses of warfarin, heparin or low molecular weight heparin throughout the study. RESULTS: Baseline mean (+/-SD) 6MWD was 477 +/- 76 m (n = 9) with mean BDS of 2.1 +/- 1.2 (n = 9). Week 12 mean 6MWD and BDS were 500 +/- 92 m and 2.3 +/- 1.7, respectively (n = 9). Four patients discontinued the study prematurely (3 AEs and 1 consent withdrawn). Adverse events included headache, flushing, and nausea. Pump complications occurred in 5 of 12 patients, and although no catheter occlusions occurred in any patient during the 12-week study, further study is needed regarding pump complications. CONCLUSION: This study demonstrates that treprostinil can be administered intravenously at infusion rates as low as 0.1 mL/hr for 12 weeks without catheter occlusions. Further studies are warranted because the potential for adverse events is of some concern.

Adult↗